Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages.

Grent-'t-Jong T, Gross J, Goense J, Wibral M, Gajwani R, Gumley AI, Lawrie SM, Schwannauer M, Schultze-Lutter F, Navarro Schröder T, Koethe D, Leweke FM, Singer W, Uhlhaas PJ.

Elife. 2018 Sep 27;7. pii: e37799. doi: 10.7554/eLife.37799.

2.

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention.

Leweke FM, Mueller JK, Lange B, Fritze S, Topor CE, Koethe D, Rohleder C.

CNS Drugs. 2018 Jul;32(7):605-619. doi: 10.1007/s40263-018-0539-z.

PMID:
30022465
3.

Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients.

Rohleder C, Koethe D, Fritze S, Topor CE, Leweke FM, Hirjak D.

Eur Arch Psychiatry Clin Neurosci. 2018 Mar 19. doi: 10.1007/s00406-018-0886-2. [Epub ahead of print]

PMID:
29556734
4.

Familial abnormalities of endocannabinoid signaling in schizophrenia.

Koethe D, Pahlisch F, Hellmich M, Rohleder C, Mueller JK, Meyer-Lindenberg A, Torrey EF, Piomelli D, Leweke FM.

World J Biol Psychiatry. 2018 Mar 22:1-9. doi: 10.1080/15622975.2018.1449966. [Epub ahead of print]

PMID:
29521179
5.

Association of anandamide with altered binocular depth inversion illusion in schizophrenia.

Reuter AR, Bumb JM, Mueller JK, Rohleder C, Pahlisch F, Hanke F, Arens E, Leweke FM, Koethe D, Schwarz E.

World J Biol Psychiatry. 2017 Sep;18(6):483-488. doi: 10.1080/15622975.2016.1246750. Epub 2016 Nov 11.

PMID:
27734750
6.

[Psychotherapeutic work with older patients].

Koethe D, Mattern M, Herpertz SC.

Nervenarzt. 2014 Nov;85(11):1345-51. doi: 10.1007/s00115-014-4087-6. German.

PMID:
25324144
7.

Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processing.

Rivolta D, Castellanos NP, Stawowsky C, Helbling S, Wibral M, Grützner C, Koethe D, Birkner K, Kranaster L, Enning F, Singer W, Leweke FM, Uhlhaas PJ.

J Neurosci. 2014 Apr 23;34(17):5909-17. doi: 10.1523/JNEUROSCI.3752-13.2014.

8.

Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study.

Schnell T, Koethe D, Krasnianski A, Gairing S, Schnell K, Daumann J, Gouzoulis-Mayfrank E.

Am J Addict. 2014 May-Jun;23(3):308-12. doi: 10.1111/j.1521-0391.2014.12126.x. Epub 2014 Mar 15.

PMID:
24628830
9.

Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders.

Schaefer C, Enning F, Mueller JK, Bumb JM, Rohleder C, Odorfer TM, Klosterkötter J, Hellmich M, Koethe D, Schmahl C, Bohus M, Leweke FM.

Eur Arch Psychiatry Clin Neurosci. 2014 Aug;264(5):459-63. doi: 10.1007/s00406-013-0470-8. Epub 2013 Nov 20.

PMID:
24253425
10.

Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia.

Sun L, Castellanos N, Grützner C, Koethe D, Rivolta D, Wibral M, Kranaster L, Singer W, Leweke MF, Uhlhaas PJ.

Schizophr Res. 2013 Nov;150(2-3):519-25. doi: 10.1016/j.schres.2013.08.023. Epub 2013 Sep 7.

PMID:
24016727
11.

Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia.

Ceccarini J, De Hert M, Van Winkel R, Peuskens J, Bormans G, Kranaster L, Enning F, Koethe D, Leweke FM, Van Laere K.

Neuroimage. 2013 Oct 1;79:304-12. doi: 10.1016/j.neuroimage.2013.04.052. Epub 2013 Apr 25.

PMID:
23624489
12.

Identification of a molecular profile associated with immune status in first-onset schizophrenia patients.

Herberth M, Rahmoune H, Schwarz E, Koethe D, Harris LW, Kranaster L, Witt SH, Spain M, Barnes A, Schmolz M, Leweke MF, Guest PC, Bahn S.

Clin Schizophr Relat Psychoses. 2014 Jan;7(4):207-15. doi: 10.3371/CSRP.HERA.020113.

PMID:
23395839
13.

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.

Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C, Klosterkötter J, Hellmich M, Koethe D.

Transl Psychiatry. 2012 Mar 20;2:e94. doi: 10.1038/tp.2012.15.

14.

Identification of a biological signature for schizophrenia in serum.

Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, van Beveren NJ, Baron-Cohen S, Steiner J, Torrey FE, Yolken RH, Bahn S.

Mol Psychiatry. 2012 May;17(5):494-502. doi: 10.1038/mp.2011.42. Epub 2011 Apr 12.

PMID:
21483431
15.

Cerebrospinal fluid diagnostics in first-episode schizophrenia.

Kranaster L, Koethe D, Hoyer C, Meyer-Lindenberg A, Leweke FM.

Eur Arch Psychiatry Clin Neurosci. 2011 Oct;261(7):529-30. doi: 10.1007/s00406-011-0193-7. Epub 2011 Feb 6.

PMID:
21298501
16.

Alterations of primary fatty acid amides in serum of patients with severe mental illness.

Schwarz E, Whitfield P, Nahnsen S, Wang L, Major H, Leweke FM, Koethe D, Lio P, Bahn S.

Front Biosci (Elite Ed). 2011 Jan 1;3:308-14.

PMID:
21196311
17.

Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival.

Herberth M, Koethe D, Levin Y, Schwarz E, Krzyszton ND, Schoeffmann S, Ruh H, Rahmoune H, Kranaster L, Schoenborn T, Leweke MF, Guest PC, Bahn S.

Proteomics. 2011 Jan;11(1):94-105. doi: 10.1002/pmic.201000291. Epub 2010 Dec 6.

PMID:
21182197
18.

Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients.

Herberth M, Koethe D, Cheng TM, Krzyszton ND, Schoeffmann S, Guest PC, Rahmoune H, Harris LW, Kranaster L, Leweke FM, Bahn S.

Mol Psychiatry. 2011 Aug;16(8):848-59. doi: 10.1038/mp.2010.71. Epub 2010 Jun 29.

PMID:
20585325
19.

Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia.

Schwarz E, Izmailov R, Spain M, Barnes A, Mapes JP, Guest PC, Rahmoune H, Pietsch S, Leweke FM, Rothermundt M, Steiner J, Koethe D, Kranaster L, Ohrmann P, Suslow T, Levin Y, Bogerts B, van Beveren NJ, McAllister G, Weber N, Niebuhr D, Cowan D, Yolken RH, Bahn S.

Biomark Insights. 2010 May 12;5:39-47.

20.

Familial differential treatment response in schizophrenia--lessons from a case of three affected siblings.

Hoyer C, Kranaster L, Leweke FM, Klosterkötter J, Meyer-Lindenberg A, Koethe D.

Pharmacopsychiatry. 2010 Jul;43(5):196-7. doi: 10.1055/s-0030-1248315. Epub 2010 Feb 26. No abstract available.

PMID:
20191444

Supplemental Content

Loading ...
Support Center